MedTrace Logo

Radicle Clarity™ RBB: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes

NCT07245784 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 850

Last updated 2025-12-22

No results posted yet for this study

Summary

A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes

Conditions

  • Cognitive Function

Interventions

DIETARY_SUPPLEMENT

Clarity Product Placebo Control

Participants will use their Clarity Product Control as directed for a period of 12 weeks

DIETARY_SUPPLEMENT

Clarity Active Product 1

Participants will use their Clarity Active Product (active ingredient: Himalayan Tartary buckwheat, a high-polyphenol non-grain fruit seed) as directed for a period of 12 weeks.

Sponsors & Collaborators

  • Jeff Bland

    collaborator UNKNOWN

  • Austin Perlmutter

    collaborator UNKNOWN

  • Radicle Science

    lead INDUSTRY

Principal Investigators

  • Susan Hewlings · Radicle Science

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-04
Primary Completion
2026-12-04
Completion
2026-12-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07245784 on ClinicalTrials.gov